| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. (AMPH) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. AMPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.00M | $59.22M | - | |
| CFO | 177.0K | $3.49M | - | |
| VP | 172.8K | $3.41M | - | |
| VP | 122.9K | $2.43M | - | |
| Dir | 71.4K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2016 | Zhang Jack Y.45 | CEO &Chief Science Officer | Sale+OE | 444,199 | $21.03 | $9,342,803.66 | -6.8% | |
| Sep 8, 2016 | Petersen Floyd F.51 | Director | Sell | 3,000 | $19.05 | $57,150.00 | -4.7% | |
| Sep 1, 2016 | Lee Howard | Director | Sale+OE | 10,381 | $18.78 | $194,916.77 | -8.3% | |
| Aug 22, 2016 | Shandell Jason B. | President And General Counsel | Sale+OE | 10,000 | $19.95 | $199,500.00 | -4.7% | |
| Aug 19, 2016 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sale+OE | 24,046 | $19.28 | $463,606.88 | -45.3% | |
| Aug 18, 2016 | Prins Richard K61 | Director | Sell | 3,086 | $19.62 | $60,539.30 | -10.6% | |
| Aug 17, 2016 | Shandell Jason B. | President And General Counsel | Sell | 5,987 | $18.86 | $112,908.83 | -2.9% | |
| Aug 16, 2016 | Shohet Stephen B. | Director | Sale+OE | 48,375 | $18.24 | $882,280.67 | -46.9% | |
| Aug 15, 2016 | Zasloff Michael A53 | Director | Sale+OE | 48,375 | $18.15 | $878,106.13 | -42.7% | |
| Aug 12, 2016 | Peters William J52 | CFO, SVP &Treasurer | Sell | 1,027 | $18.19 | $18,680.72 | -1.6% |